GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

While the FTSE 100 powers higher, Wall Street remains contained following its rebound earlier in the week, says Chris ...

Schneider Electric, today announced continued progress toward decarbonization for the pharmaceutical and healthcare sectors.

Yet GSK is clearly healing from its multiple comorbidities — the worst of which was the (now largely resolved) legal overhang related to heartburn medicine Zantac. Chief executive Emma Walmsley also ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of ...

GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...

Service charges Surprise residents and visitors pay when applying for permits or renting out city parks and pools will likely ...

Individual patient data from neoadjuvant randomized breast cancer clinical trials with available data on pathologic complete ...

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's ...

The Orlando Magic ended a four-game losing streak in a big way Wednesday, scoring 130 points in a runaway victory at Sacramento.

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...